$CLVS Already up 3% PM! Bounce to $12-14++ today! HCW PT $27.00 “2020 key milestones include further EU roll-outs for Rubraca, a potential US Rubraca launch in prostate cancer, initial data for lucitanib combination studies, and a planned investigational new drug filing for FAP-2286 in H2.”
  • 1
  • 1